Ep125: Barry Greene on a New Drug for Depression episode artwork

EPISODE · Dec 19, 2022 · 1H 4M

Ep125: Barry Greene on a New Drug for Depression

from The Long Run with Luke Timmerman · host Timmerman Report

Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.

Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.

NOW PLAYING

Ep125: Barry Greene on a New Drug for Depression

0:00 1:04:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 4 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on December 19, 2022.

What is this episode about?

Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.

Can I download this The Long Run with Luke Timmerman episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!